Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Forman

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
Annals of Neurology|May 24, 2006
Frontotemporal dementia: clinicopathological correlationsMark S Forman, Jennifer Farmer, Julene K Johnson, et al.
Journal of Clinical Microbiology|November 9, 2007
Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virusR T Hayden, K M Hokanson, S B Pounds, et al.
Journal of Neuropathology and Experimental Neurology|June 20, 2006
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutationsMark S Forman, Ian R Mackenzie, Nigel J Cairns, et al.
Blood|April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapyG Somlo, I Sniecinski, A ter Veer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients' Perspectives on Risks, Monitoring, and GuidelinesJonathan Colasanti, Marlene C Lira, Debbie M Cheng, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 7, 2007
Factors associated with survival probability in autopsy-proven frontotemporal lobar degenerationS X Xie, M S Forman, J Farmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2020
Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical TrialJeffrey H Samet, Judith I Tsui, Debbie M Cheng, et al.
American Journal of Alzheimer'S Disease and Other Dementias|January 2, 2008
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degenerationG D Rabinovici, W W Seeley, E J Kim, et al.
Alcohol, Clinical & Experimental Research|February 17, 2023
Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIVNicolas Bertholet, Richard Saitz, Judith A Hahn, et al.
Psychosomatic Medicine|March 10, 1998
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measuresP G Kaufmann, R P McMahon, L C Becker, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Annals of Neurology|May 24, 2006
Frontotemporal dementia: clinicopathological correlationsMark S Forman, Jennifer Farmer, Julene K Johnson, et al.
Journal of Clinical Microbiology|November 9, 2007
Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virusR T Hayden, K M Hokanson, S B Pounds, et al.
Journal of Neuropathology and Experimental Neurology|June 20, 2006
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutationsMark S Forman, Ian R Mackenzie, Nigel J Cairns, et al.
Blood|April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapyG Somlo, I Sniecinski, A ter Veer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients' Perspectives on Risks, Monitoring, and GuidelinesJonathan Colasanti, Marlene C Lira, Debbie M Cheng, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 7, 2007
Factors associated with survival probability in autopsy-proven frontotemporal lobar degenerationS X Xie, M S Forman, J Farmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2020
Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical TrialJeffrey H Samet, Judith I Tsui, Debbie M Cheng, et al.
American Journal of Alzheimer'S Disease and Other Dementias|January 2, 2008
Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degenerationG D Rabinovici, W W Seeley, E J Kim, et al.
Alcohol, Clinical & Experimental Research|February 17, 2023
Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIVNicolas Bertholet, Richard Saitz, Judith A Hahn, et al.
Psychosomatic Medicine|March 10, 1998
The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measuresP G Kaufmann, R P McMahon, L C Becker, et al.
Pageof 30